Eagle Health Investments’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $23.9M | Sell |
273,821
-83,100
| -23% | -$7.25M | 5.9% | 7 |
|
|
2025
Q1 | $24.4M | Buy |
356,921
+82,370
| +30% | +$5.63M | 6.33% | 8 |
|
|
2024
Q4 | $21.4M | Sell |
274,551
-176,941
| -39% | -$13.8M | 5.23% | 9 |
|
|
2024
Q3 | $30.3M | Buy |
451,492
+175,774
| +64% | +$11.8M | 5.73% | 8 |
|
|
2024
Q2 | $31.3M | Sell |
275,718
-9,200
| -3% | -$1.04M | 5.48% | 8 |
|
|
2024
Q1 | $39.5M | Sell |
284,918
-24,400
| -8% | -$3.38M | 7.34% | 5 |
|
|
2023
Q4 | $38.4M | Buy |
309,318
+33,213
| +12% | +$4.12M | 7.8% | 5 |
|
|
2023
Q3 | $25.8M | Buy |
276,105
+113,705
| +70% | +$10.6M | 5.68% | 8 |
|
|
2023
Q2 | $20.9M | Sell |
162,400
-69,200
| -30% | -$8.89M | 3.9% | 13 |
|
|
2023
Q1 | $26.9M | Buy |
231,600
+12,600
| +6% | +$1.46M | 5.24% | 9 |
|
|
2022
Q4 | $24.8M | Sell |
219,000
-46,800
| -18% | -$5.3M | 5.72% | 10 |
|
|
2022
Q3 | $21.4M | Buy |
265,800
+28,700
| +12% | +$2.31M | 4.91% | 10 |
|
|
2022
Q2 | $17.7M | Buy |
237,100
+81,500
| +52% | +$6.07M | 4.12% | 10 |
|
|
2022
Q1 | $19.9M | Buy |
155,600
+48,800
| +46% | +$6.24M | 4.9% | 9 |
|
|
2021
Q4 | $14.3M | Sell |
106,800
-11,200
| -9% | -$1.5M | 3.49% | 15 |
|
|
2021
Q3 | $16.1M | Sell |
118,000
-18,800
| -14% | -$2.57M | 5.12% | 10 |
|
|
2021
Q2 | $14.6M | Buy |
136,800
+81,600
| +148% | +$8.71M | 5.01% | 9 |
|
|
2021
Q1 | $4.96M | Hold |
55,200
| – | – | 1.95% | 18 |
|
|
2020
Q4 | $5.1M | Buy |
+55,200
| New | +$5.1M | 3.26% | 14 |
|